Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,641.50

7.35 (0.45%)

, WBA

Walgreens Boots Alliance

$71.71

0.12 (0.17%)

09:18
01/24/19
01/24
09:18
01/24/19
09:18

Jefferies finds nine more Rx licenses for PillPack facility in Arizona

Jefferies analyst Brian Tanquilut says his monthly checks with state boards of pharmacy reveal that PillPack's Arizona facility has been granted nine additional prescription licenses. The analyst expects Amazon (AMZN) will continue to pursue Rx licenses for PillPack's Arizona pharmacy in all the remaining states over the next six months. However, the company will still have to acquire or build a few more mail pharmacies and grow capacity before being able to go live with a consumer pharmacy offering, Tanquilut tells investors in a research note. Further, his monthly webscrape of Amazon's healthcare-related private label products indicates that the company's Solimo offering's growth accelerated significantly month-over-month in January. On private label over-the-counter drugs, Walgreens Boots Alliance (WBA) remains more expensive than Amazon's Basic Care offering, while CVS Health's (CVS) net prices are slightly more competitive due to higher discounting, Tanquilut says.

AMZN

Amazon.com

$1,641.50

7.35 (0.45%)

WBA

Walgreens Boots Alliance

$71.71

0.12 (0.17%)

CVS

CVS Health

$65.63

1.24 (1.93%)

  • 25

    Jan

  • 28

    Jan

  • 31

    Jan

  • 04

    Feb

  • 20

    Feb

  • 03

    Mar

AMZN Amazon.com
$1,641.50

7.35 (0.45%)

01/17/19
MSCO
01/17/19
NO CHANGE
Target $99
MSCO
Overweight
PayPal merchant acceptance lead widened in Q4, says Morgan Stanley
Morgan Stanley analyst James Faucette said that PayPal (PYPL) widened its merchant acceptance lead in Q4 as it added a net of 8 of the U.S.'s top 500 internet retailers while the next largest accepted digital wallet, Amazon Pay (AMZN), lost 4 net merchants this quarter. PayPal now has acceptance at 82% of the top 500 U.S. Internet retailers, up from 81% last quarter, while Amazon's acceptance rate slipped to 12% from 13%. MasterCard's (MA) MasterPass gained 1 net new merchant, Visa Checkout (V) gained no net new merchants and Bitcoin acceptance remained unchanged at 4 of the top 500, Faucette added. The analyst, who think PayPal's acceptance lead and consumers' shift toward online purchases should support total payments volume growth at or above the rate of e-commerce, keeps an Overweight rating on PayPal shares and raised his price target to $99 from $97.
01/17/19
RBCM
01/17/19
NO CHANGE
Target $20
RBCM
United Natural Foods price target lowered to $20 from $24 at RBC Capital
RBC Capital analyst William Kirk lowered his price target on United Natural Foods (UNFI) to $20 and kept his Sector Perform rating after its ICR conference presentation. The analyst notes that while the discussions supported his view of "favorable macro trends" in terms of freight, gas, and inflation costs, he is concerned with the risk around the company's "out-year synergies" around the integration of its Supervalu acquisition. Kirk further warns that Amazon (AMZN) Whole Foods combination has the "ability, incentive, and precedent history to de-emphasize" United Natural Foods business.
01/22/19
RHCO
01/22/19
NO CHANGE
Target $2250
RHCO
Buy
Amazon.com remains 'compelling' on private label dominance, says SunTrust
SunTrust analyst Youssef Squali kept his Buy rating and $2,250 price target on Amazon.com but raised his outlook for revenue in FY22 to $31B from $25B, noting that he sees the company's private label sales growing strongly with estimated 40% increase this year. The analyst states that Amazon's "rise of private labels and exclusives is one of the least understood / most under-appreciated trends" for the company, and that the competitive advantage derived from it is hard to dislodge. Squali adds that the strategy also strengthens Amazon's "flywheel effect" of proprietary offerings, creates better user experience, and should support its margins over time.
01/23/19
BARD
01/23/19
NO CHANGE
Target $2100
BARD
Amazon Q4 results should be in-line, guidance could be 'noisy,' says Baird
Baird analyst Colin Sebastian said holiday e-commerce trends suggest an in-line Q4 for Amazon, which translates into revenue being at the high end of guidance. However, the analyst believes Q1 guidance could be "noisy". He said recent changes to third-party marketplace/FBA fees, India regulations, and macro softness in the UK could muddy the near-term revenue and margin guidance, which keeps him below consensus for Q1. Sebastian reiterated his Outperform rating and $2,100 price target on Amazon.com shares.
WBA Walgreens Boots Alliance
$71.71

0.12 (0.17%)

01/17/19
01/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tencent Music (TME) initiated with an Overweight at JPMorgan. 2. Craft Brew (BREW) initiated with a Buy at Maxim while Castle Brands (ROX) was initiated with a Hold. 3. CVS Health (CVS) and LabCorp (LH) were initiated with a Buy at UBS while Walgreens Boots Alliance (WBA) was initiated with a Sell. 4. DTE Energy (DTE) initiated with a Buy at Goldman Sachs while CMS Energy (CMS) was initiated with a Neutral. 5. Zendesk (ZEN) and HubSpot (HUBS) were initiated with an Overweight at Stephens while Adobe (ADBE) was initiated with an Equal Weight. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/16/19
MSCO
01/16/19
NO CHANGE
MSCO
Morgan Stanley says UnitedHealth, Walgreens could benefit from CVS-Walmart fight
After CVS Health (CVS) announced Walmart (WMT) will leave Caremark's commercial and Managed Medicaid retail pharmacy networks at the end of April 2019, analysts at Morgan Stanley discussed the potential impact of the fight to both companies and to competitors. Analyst Ricky Goldwasser said the dispute "brings back memories" of the Express Scripts (ESRX) and Walgreens (WBA) breakup in 2011, but unlike in that case it is only the early days of the 2019/2020 selling season, not after the selling season concluded. Walmart's plans to leave should have a limited impact on CVS' FY19 EPS power, but adds uncertainty to PBM selling season if not resolved in the near-term, said Goldwasser. Morgan Stanley's Simeon Gutman said that if the dispute is not resolved, it could end up reducing Walmart's EBIT by about $260M in 2019, which he estimates could have a 7c, or 1.5%, impact on EPS. In terms of who may benefit if no resolution is reached, the team estimates both Walgreens and CVS retail could gain an incremental 25 bps of pharmacy share and that UnitedHealth's (UNH) Optum and Cigna (CI) could see a step up in PBM selling season win rates. However, given Walmart's relatively low share, they view the PBM share opportunity as "minimal."
01/17/19
UBSW
01/17/19
INITIATION
Target $70
UBSW
Sell
Walgreens Boots Alliance initiated with a Sell at UBS
UBS analyst Kevin Caliendo started Walgreens Boots Alliance with a Sell rating and $70 price target. The analyst's work suggests the company's core retail margins will stay pressured over the next several years. Further, he believes Walgreens' industry dynamics remain challenging.
01/23/19
LOOP
01/23/19
NO CHANGE
Target $82
LOOP
Buy
Walgreens already reserved for DOJ settlement, says Loop Capital
After speaking with management at Walgreens Boots Alliance regarding the unsealing of the company's $269M settlement with the Department of Justice for overbilling, Loop Capital analyst Andrew Wolf said his key takeaways were that the fines were already reserved for, so there should be no go-forward financial impact, and that company's most recent 10-Q had referenced the matter. Wolf, who views the unsealing of the settlement as "a final and more specific rendering of previously released news," does not expect the news to have a material impact on the stock. He keeps a Buy rating and $82 price target on Walgreens shares.
CVS CVS Health
$65.63

1.24 (1.93%)

01/17/19
UBSW
01/17/19
INITIATION
Target $75
UBSW
Buy
CVS Health initiated with a Buy at UBS
UBS analyst Kevin Caliendo started CVS Health with a Buy rating and $75 price target. Concerns around 2019 earnings guidance and the timing of the next positive catalyst have pushed CVS stock down to a "very appealing" risk/reward profile, Caliendo tells investors in a research stone.
01/14/19
COWN
01/14/19
NO CHANGE
Target $103
COWN
Outperform
CVS Health headwind concerns overblown, says Cowen
Cowen analyst Charles Ryhee updated his model on CVS (CVS) to reflect headwinds from rebate guarantees and Aetna's (AET) large group rated business. He believes the pressure on the shares due to rebate guarantees is overdone in that it represents less than 2% of its revenues. Ryhee reiterated his Outperform rating and $103 price target on CVS shares.

TODAY'S FREE FLY STORIES

21:25
03/25/19
03/25
21:25
03/25/19
21:25
General news
Fed's Rosengren warned that U.S. Q1 growth is likely to be weak »

Fed's Rosengren…

BBBY

Bed Bath & Beyond

$13.87

0.17 (1.24%)

20:44
03/25/19
03/25
20:44
03/25/19
20:44
Periodicals
Activist firms seek to replace Bed Bath & Beyond board, CEO, WSJ says »

Activist funds -Legion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Apr

RTN

Raytheon

$180.58

-0.82 (-0.45%)

, BA

Boeing

$370.52

8.37 (2.31%)

20:36
03/25/19
03/25
20:36
03/25/19
20:36
Hot Stocks
Raytheon kill vehicle hits ICBM target in first dual-salvo test »

For the first time, the…

RTN

Raytheon

$180.58

-0.82 (-0.45%)

BA

Boeing

$370.52

8.37 (2.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

20:35
03/25/19
03/25
20:35
03/25/19
20:35
General news
The "Summary of Opinions" from the BoJ's March meeting »

The "Summary of…

WHD

Cactus

$36.03

1.225 (3.52%)

20:27
03/25/19
03/25
20:27
03/25/19
20:27
Hot Stocks
Cactus VP of Operations sells 229K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$56.67

-0.065 (-0.11%)

, MKC

McCormick

$143.88

1.58 (1.11%)

20:25
03/25/19
03/25
20:25
03/25/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

CCL

Carnival

$56.67

-0.065 (-0.11%)

MKC

McCormick

$143.88

1.58 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 27

    Mar

CRTO

Criteo

$21.99

-3.4 (-13.39%)

20:19
03/25/19
03/25
20:19
03/25/19
20:19
Downgrade
Criteo rating change at KeyBanc »

Criteo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

$0.00

(0.00%)

20:02
03/25/19
03/25
20:02
03/25/19
20:02
Periodicals
Samsung sees weaker environment for display, memory in Q1, Bloomberg says »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$370.52

8.37 (2.31%)

19:51
03/25/19
03/25
19:51
03/25/19
19:51
Hot Stocks
U.S. MDA and Boeing Complete Historic Missile Defense Test »

The U.S. Missile Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

MCD

McDonald's

$185.66

-1.11 (-0.59%)

19:49
03/25/19
03/25
19:49
03/25/19
19:49
Periodicals
McDonald's purchase price of Dynamic Yield above $300M, Bloomberg says »

The purchase of Dynamic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 28

    May

SSNLF

Samsung

$0.00

(0.00%)

19:32
03/25/19
03/25
19:32
03/25/19
19:32
Periodicals
Breaking Periodicals news story on Samsung »

Samsung sees Q1 below…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWR

American States Water

$71.51

0.505 (0.71%)

19:22
03/25/19
03/25
19:22
03/25/19
19:22
Hot Stocks
American States Water CEO sells 12.4K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MEOH

Methanex

$56.35

-1.38 (-2.39%)

19:10
03/25/19
03/25
19:10
03/25/19
19:10
Hot Stocks
Methanex confirms receipt of director nominees notice from M&G »

Methanex Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$34.14

0.81 (2.43%)

, SAEX

SAExploration

$4.03

0.13 (3.33%)

18:55
03/25/19
03/25
18:55
03/25/19
18:55
Hot Stocks
Fly Intel: After Hours Movers »

DOWN AFTER EARNINGS:…

BECN

Beacon Roofing

$34.14

0.81 (2.43%)

SAEX

SAExploration

$4.03

0.13 (3.33%)

IQ

iQIYI

$24.01

-0.86 (-3.46%)

MYOK

MyoKardia

$51.87

-2.44 (-4.49%)

CTMX

CytomX Therapeutics

$10.76

0.33 (3.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 26

    Mar

  • 21

    May

  • 27

    Mar

HPQ

HP Inc.

$18.97

-0.4 (-2.07%)

18:48
03/25/19
03/25
18:48
03/25/19
18:48
Periodicals
HP lawyer tells court Autonomy's Lynch inflated sales data, Reuters says »

A lawyer for HP told a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

PEGA

Pegasystems

$63.61

-0.27 (-0.42%)

18:45
03/25/19
03/25
18:45
03/25/19
18:45
Hot Stocks
Pegasystems CEO: We are massively changing our marketing strategy »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

SMTC

Semtech

$52.59

-0.38 (-0.72%)

18:32
03/25/19
03/25
18:32
03/25/19
18:32
Hot Stocks
Semtech CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

TMO

Thermo Fisher

$268.89

5.015 (1.90%)

18:24
03/25/19
03/25
18:24
03/25/19
18:24
Hot Stocks
Thermo Fisher CEO: We have a very disciplined M&A process »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

, SPX

S&P 500

$0.00

(0.00%)

18:24
03/25/19
03/25
18:24
03/25/19
18:24
Periodicals
Parliament forces votes on Brexit plan options, Bloomberg reports »

Lawmakers of U.K.…

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$278.99

-0.56 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$185.66

-1.11 (-0.59%)

18:23
03/25/19
03/25
18:23
03/25/19
18:23
Hot Stocks
McDonald's to acquire Dynamic Yield, terms not stated »

McDonald's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 28

    May

BA

Boeing

$370.52

8.37 (2.31%)

18:22
03/25/19
03/25
18:22
03/25/19
18:22
Periodicals
Boeing software fix to prevent repeated activiation of MCAS, Reuters says »

A Boeing software repair…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ACHC

Acadia

$29.47

-0.59 (-1.96%)

17:58
03/25/19
03/25
17:58
03/25/19
17:58
Hot Stocks
Acadia says President Brett Turner leaving by mutual agreement »

Brent Turner, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$188.78

-2.33 (-1.22%)

17:41
03/25/19
03/25
17:41
03/25/19
17:41
Recommendations
Apple analyst commentary at Piper Jaffray »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 03

    Jun

ZFGN

Zafgen

$2.70

-0.15 (-5.26%)

17:38
03/25/19
03/25
17:38
03/25/19
17:38
Hot Stocks
Armistice Capital reports 5.6% passive stake in Zafgen »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$268.56

0.27 (0.10%)

17:36
03/25/19
03/25
17:36
03/25/19
17:36
Hot Stocks
Northrop Grumman awarded $245.05M Navy contract modification »

Northrop Grumman has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.